Home SAFE Act would classify any fentanyl-related substance as a Schedule I drug
Local

SAFE Act would classify any fentanyl-related substance as a Schedule I drug

Contributors
healthcare
(© BillionPhotos.com – stock.adobe.com)

According to a Pew study released earlier this year, more Americans died from overdose in 2020 than any previous year on record — and some figures indicate that 2021’s death toll may be higher.

The same study showed that approximately 75 percent of all fatal overdoses in 2020 involved opioids, including more than six in 10 involving synthetic opioids — like fentanyl.

Fentanyl-related substances are currently on a temporary scheduling for Schedule I classification. This Schedule I classification expired last week, and will require repeated congressional extensions — barring Congress making it permanent.

The Abigail Spanberger-cosponsored Save Americans from the Fentanyl Emergency (SAFE) Act would make this Schedule I classification permanent. In doing so, the bill would make sure Virginia law enforcement departments can keep prosecuting the sale and use of these substances.

“Fentanyl has been responsible for devastation, heartbreak, and loss in far too many Virginia communities. To make sure law enforcement can keep fentanyl off our streets, we need to take the long overdue step of classifying it as a Schedule I drug — permanently,” said Spanberger (D-VA-07). “As a former federal agent who worked narcotics cases, I understand how this deadly substance can weave its way into illicit drug networks and literally kill unsuspecting addicts. Those who distribute such a dangerous drug should be punished to the full extent of the law, and the SAFE Act would make sure justice is served.”

The bipartisan SAFE Act is led by Reps. Chris Pappas (D-NH-01), Dan Newhouse (R-WA-04), and Ted Budd (R-NC-13).

Specifically, the SAFE Act would:

  • Amend Section 202(c) of the Controlled Substances Act to permanently classify any fentanyl-related substance as a Schedule I drug unless it is already listed in another schedule or specifically exempted.
  • Define the types of compounds and molecular variations that count as an analogue of fentanyl.
  • Require the Attorney General to publish a list of substances that meet the classification of a fentanyl-related substance in the Federal Register within 60 days of determination.
  • Allow the Secretary of HHS to contract with private entities to conduct research and evaluations into fentanyl-related substances, and create a streamlined process to facilitate research of controlled substances in Schedule I to more closely align it with the process for Schedule II research, to expand our understanding of fentanyl-related substances and other drugs.
  • Require the GAO to issue a report within four years after enactment analyzing the effect of permanent scheduling of fentanyl analogues. The report would analyze impact on research, removal or rescheduling of analogues, manufacturing/trafficking, criminal charges, and overall efficacy on reducing proliferation of fentanyl-related substances.
  • Click here to read the full bill text.

Contributors

Contributors

Have a guest column, letter to the editor, story idea or a news tip? Email editor Chris Graham at [email protected]. Subscribe to AFP podcasts on Apple PodcastsSpotifyPandora and YouTube.